Analystreport

Intercept Pharmaceuticals Inc (NASDAQ: ICPT) is now covered by analysts at B. Riley. They set a "buy" rating and a $155.00 price target on the stock.

Intercept Pharmaceuticals, Inc.  (ICPT) 
Last intercept pharmaceuticals, inc. earnings: 2/25 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.interceptpharma.com/investor-relations